About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 983902, 8 pages
http://dx.doi.org/10.1155/2013/983902
Review Article

Correlations between Psoriasis and Inflammatory Bowel Diseases

Department of Dermatology “Daniele Innocenzi”, A. Fiorini Hospital, Sapienza University of Rome, Via Firenze, Polo Pontino, 04019 Terracina, Italy

Received 17 April 2013; Accepted 27 June 2013

Academic Editor: Oliver Stoeltzing

Copyright © 2013 Nevena Skroza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Rudikoff, J. Baral, and M. Lebwohl, “Psoriasis and Crohn's disease,” The Mount Sinai Journal of Medicine, vol. 66, article 206, 1999. View at Scopus
  2. R. Hoffmann, G. Schieferstein, F. Schunter, and H. Jenss, “Re: increased occurrence of psoriasis in patients with Crohn's disease and their relatives,” The American Journal of Gastroenterology, vol. 86, no. 6, pp. 787–788, 1991. View at Scopus
  3. C. Potenza, A. Annetta, N. Bernardini et al., Plaque Psoriasis: Anatomical, Clinical and Immunohistochemical Correlations During Anti-Tnfa Treatment, vol. 1, J. Medical Books edizioni Srl, Viareggio, Italy, 2010.
  4. B. Hammer, P. Ashurst, and J. Naish, “Diseases associated with ulcerative colitis and Crohn's disease,” Gut, vol. 9, no. 1, pp. 17–21, 1968. View at Scopus
  5. T. Yamamoto and A. Yokoyama, “Coexistence of psoriasis vulgaris, ulcerative colitis, and thyroid adenoma,” Journal of Dermatology, vol. 24, no. 4, pp. 275–276, 1997. View at Scopus
  6. C. McEwen, D. DiTata, C. Lingg, A. Porini, A. Good, and T. Rankin, “Ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, psoriasis and Reiter's disease. A comparative study,” Arthritis and Rheumatism, vol. 14, no. 3, pp. 291–318, 1971. View at Scopus
  7. J. Oestreicher, I. Walters, T. Kikuchi, P. Gilleaudeau, J. Surette, U. Schwertschlag, et al., “Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling,” Pharmacogenomics Journal, vol. 1, no. 4, pp. 272–287, 2001.
  8. E. M. Farber, M. L. Nall, and W. Watson, “Natural history of psoriasis in 61 twin pairs,” Archives of Dermatology, vol. 109, no. 2, pp. 207–211, 1974. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Friedman and R. S. Blumberg, “Inflammatory bowel disease,” in Harrison’s Principles of Internal Medicine, E. Braunwald, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo, and J. L. Jameson VII, Eds., pp. 1679–1686, McGraw-Hill, New York, NY, USA, 2001.
  10. H. Yang, S. E. Plevy, K. Taylor et al., “Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses,” Gut, vol. 44, no. 4, pp. 519–526, 1999. View at Scopus
  11. D. A. Watts and J. Satsangi, “The genetic jigsaw of inflammatory bowel disease,” Gut, vol. 50, no. 3, pp. iii31–iii36, 2002. View at Scopus
  12. R. P. Nair, T. Henseler, S. Jenisch et al., “Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan,” Human Molecular Genetics, vol. 6, no. 8, pp. 1349–1356, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. F. I. Lee, S. V. Bellary, and C. Francis, “Increased occurrence of psoriasis in patients with Crohn's disease and their relatives,” The American Journal of Gastroenterology, vol. 85, no. 8, pp. 962–963, 1990. View at Scopus
  14. C. N. Bernstein, A. Wajda, and J. F. Blanchard, “The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study,” Gastroenterology, vol. 129, no. 3, pp. 827–836, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. D. Cohen, J. Dreiher, and S. Birkenfeld, “Psoriasis associated with ulcerative colitis and Crohn's disease,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 5, pp. 561–565, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Christophers, “Comorbidities in psoriasis,” Clinics in Dermatology, vol. 25, no. 6, pp. 529–534, 2007.
  17. P. R. Burton, D. G. Clayton, L. R. Cardon et al., “Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls,” Nature, vol. 447, no. 7145, pp. 661–678, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Wolf, M. Quaranta, N. J. Prescott et al., “Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease,” Journal of Medical Genetics, vol. 45, no. 2, pp. 114–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Zeggini, M. N. Weedon, C. M. Lindgren et al., “Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes,” Science, vol. 316, no. 5829, pp. 1336–1341, 2007, Erratum in Science, vol. 317, pp. 1035-1036, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Ogura, D. K. Bonen, N. Inohara et al., “A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease,” Nature, vol. 411, no. 6837, pp. 603–606, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. D. K. Bonen and J. H. Cho, “The genetics of inflammatory bowel disease,” Gastroenterology, vol. 124, no. 2, pp. 521–536, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Lesage, H. Zouali, J.-P. Cézard et al., “CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease,” The American Journal of Human Genetics, vol. 70, no. 4, pp. 845–857, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Inohara and G. Nuñez, “NODS: intracellular proteins involved in inflammation and apoptosis,” Nature Reviews Immunology, vol. 3, no. 5, pp. 371–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Watanabe, A. Kitani, P. J. Murray, and W. Strober, “NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses,” Nature Immunology, vol. 5, no. 8, pp. 800–808, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. P. Nair, P. Stuart, Y. Ogura et al., “Lack of association between NOD2 3020insC frameshift mutation and psoriasis,” Journal of Investigative Dermatology, vol. 117, no. 6, pp. 1671–1672, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Zhu, X. Yin, X. Tang, F. Zhang, S. Yang, and X. Zhang, “Meta-analysis of NOD2/CARD15 polymorphisms with psoriasis and psoriatic arthritis,” Rheumatology International, vol. 32, no. 7, pp. 1893–1900, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S.-K. Yang, E. V. Loftus Jr., and W. J. Sandborn, “Epidemiology of inflammatory bowel disease in Asia,” Inflammatory Bowel Diseases, vol. 7, no. 3, pp. 260–270, 2001. View at Scopus
  28. M. Cargill, S. J. Schrodi, M. Chang et al., “A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes,” The American Journal of Human Genetics, vol. 80, no. 2, pp. 273–290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. L. Smith, R. B. Warren, S. Eyre et al., “Polymorphisms in the IL-12βand IL-23R genes are associated with psoriasis of early onset in a UK cohort,” Journal of Investigative Dermatology, vol. 128, no. 5, pp. 1325–1327, 2008.
  30. F. Capon, P. di Meglio, J. Szaub et al., “Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis,” Human Genetics, vol. 122, no. 2, pp. 201–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. P. Nair, A. Ruether, P. E. Stuart et al., “Polymorphisms of the IL12B and IL23R genes are associated with psoriasis,” Journal of Investigative Dermatology, vol. 128, no. 7, pp. 1653–1661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Chandran, “Genetics of psoriasis and psoriatic arthritis,” The Indian Journal of Dermatology, vol. 55, no. 2, pp. 151–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. P. Nair, P. E. Stuart, I. Nistor et al., “Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene,” The American Journal of Human Genetics, vol. 78, no. 5, pp. 827–851, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. E. Gudjonsson, A. Karason, E. H. Runarsdottir et al., “Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients—an analysis of 1019 HLA-C- and HLA-B-typed patients,” Journal of Investigative Dermatology, vol. 126, no. 4, pp. 740–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. J. Najarian and A. B. Gottlieb, “Connections between psoriasis and Crohn’s disease,” Journal of the American Academy of Dermatology, vol. 48, no. 6, pp. 805–821, 2003.
  36. C. Friberg, K. Björck, S. Nilsson, A. Inerot, J. Wahlström, and L. Samuelsson, “Analysis of chromosome 5q31-32 and psoriasis: confirmation of a susceptibility locus but no association with SNPs within SLC22A4 and SLC22A5,” Journal of Investigative Dermatology, vol. 126, no. 5, pp. 998–1002, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Li, M. Chang, S. J. Schrodi et al., “The 5q31 variants associated with psoriasis and Crohn's disease are distinct,” Human Molecular Genetics, vol. 17, no. 19, pp. 2978–2985, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Chang, Y. Li, C. Yan et al., “Variants in the 5q31 cytokine gene cluster are associated with psoriasis,” Genes and Immunity, vol. 9, no. 2, pp. 176–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Stockinger and M. Veldhoen, “Differentiation and function of Th17 T cells,” Current Opinion in Immunology, vol. 19, no. 3, pp. 281–286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Steinman, “A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage,” Nature Medicine, vol. 13, no. 2, pp. 139–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Manel, D. Unutmaz, and D. R. Littman, “The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt,” Nature Immunology, vol. 9, no. 6, pp. 641–649, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Ouyang, J. K. Kolls, and Y. Zheng, “The biological functions of T helper 17 cell effector cytokines in inflammation,” Immunity, vol. 28, no. 4, pp. 454–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Korn, E. Bettelli, W. Gao et al., “IL-21 initiates an alternative pathway to induce proinflammatory T H17 cells,” Nature, vol. 448, no. 7152, pp. 484–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Ye, P. B. Garvey, P. Zhang et al., “Interleukin-17 and lung host defense against klebsiella pneumoniae infection,” The American Journal of Respiratory Cell and Molecular Biology, vol. 25, no. 3, pp. 335–340, 2001. View at Scopus
  46. C. Infante-Duarte, H. F. Horton, M. C. Byrne, and T. Kamradt, “Microbial lipopeptides induce the production of IL-17 in Th cells,” Journal of Immunology, vol. 165, no. 11, pp. 6107–6115, 2000. View at Scopus
  47. S. A. Khader and A. M. Cooper, “IL-23 and IL-17 in tuberculosis,” Cytokine, vol. 41, no. 2, pp. 79–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Huang, L. Na, P. L. Fidel, and P. Schwarzenberger, “Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice,” Journal of Infectious Diseases, vol. 190, no. 3, pp. 624–631, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Oppmann, R. Lesley, B. Blom et al., “Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12,” Immunity, vol. 13, no. 5, pp. 715–725, 2000. View at Scopus
  50. S. Fujino, A. Andoh, S. Bamba et al., “Increased expression of interleukin 17 in inflammatory bowel disease,” Gut, vol. 52, no. 1, pp. 65–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Fitch, E. Harper, I. Skorcheva, S. E. Kurtz, and A. Blauvelt, “Pathophysiology of psoriasis: recent advances on IL-23 and TH17 cytokines,” Current Rheumatology Reports, vol. 9, no. 6, pp. 461–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Asarch, O. Barak, D. S. Loo, and A. B. Gottlieb, “Th17 cells: a new paradigm for cutaneous inflammation,” Journal of Dermatological Treatment, vol. 19, no. 5, pp. 259–266, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Lee, W. L. Trepicchio, J. L. Oestreicher et al., “Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris,” Journal of Experimental Medicine, vol. 199, no. 1, pp. 125–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Sabat, S. Philipp, C. Höflich, et al., “Immunopathogenesis of psoriasis,” Experimental Dermatology, vol. 16, no. 10, pp. 779–798, 2007.
  55. K. Wolk, E. Witte, E. Wallace et al., “IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis,” The European Journal of Immunology, vol. 36, no. 5, pp. 1309–1323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Toda, D. Y. M. Leung, S. Molet et al., “Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions,” Journal of Allergy and Clinical Immunology, vol. 111, no. 4, pp. 875–881, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Sakaguchi and F. Powrie, “Emerging challenges in regulatory T cell function and biology,” Science, vol. 317, no. 5838, pp. 627–629, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Zhang and Y. Zhao, “The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: multiple pathways on the road,” Journal of Cellular Physiology, vol. 211, no. 3, pp. 590–597, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Fattorossi, A. Battaglia, A. Buzzonetti, F. Ciaraffa, G. Scambia, and A. Evoli, “Circulating and thymic CD4+ CD25+ T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment,” Immunology, vol. 116, no. 1, pp. 134–141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. M.-F. Liu, L.-H. Lin, C.-T. Weng, and M.-Y. Weng, “Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjögren's syndrome,” Lupus, vol. 17, no. 1, pp. 34–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Zhang, X. Zhang, F. Tang, L. Zhu, and Y. Liu, “Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus,” Clinical and Experimental Immunology, vol. 153, no. 2, pp. 182–187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. C.-M. Wei, J.-H. Lee, L.-C. Wang, Y.-H. Yang, L.-Y. Chang, and B.-L. Chiang, “Frequency and phenotypic analysis of CD4+CD25+ regulatory T cells in children with juvenile idiopathic arthritis,” Journal of Microbiology, Immunology and Infection, vol. 41, no. 1, pp. 78–87, 2008. View at Scopus
  63. M. R. Ehrenstein, J. G. Evans, A. Singh et al., “Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy,” Journal of Experimental Medicine, vol. 200, no. 3, pp. 277–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Lindley, C. M. Dayan, A. Bishop, B. O. Roep, M. Peatman, and T. I. M. Tree, “Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes,” Diabetes, vol. 54, no. 1, pp. 92–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Saruta, Q. T. Yu, P. R. Fleshner et al., “Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease,” Clinical Immunology, vol. 125, no. 3, pp. 281–290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. Q. T. Yu, M. Saruta, A. Avanesyan, P. R. Fleshner, A. H. Banham, and K. A. Papadakis, “Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis,” Inflammatory Bowel Diseases, vol. 13, no. 2, pp. 191–199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Hirahara, L. Liu, R. A. Clark, K.-I. Yamanaka, R. C. Fuhlbrigge, and T. S. Kupper, “The majority of human peripheral blood CD4+CD25 highFoxp3+ regulatory T cells bear functional skin-homing receptors,” Journal of Immunology, vol. 177, no. 7, pp. 4488–4494, 2006. View at Scopus
  68. H. J. Bovenschen, I. M. J. J. van Vlijmen-Willems, P. C. M. van de Kerkhof, and P. E. J. van Erp, “Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in psoriasis,” Dermatology, vol. 213, no. 2, pp. 111–117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Radhakrishnan, R. Cabrera, E. L. Schenk et al., “Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo,” Journal of Immunology, vol. 181, no. 5, pp. 3137–3147, 2008. View at Scopus
  71. M. Oukka, “Interplay between pathogenic Th17 and regulatory T cells,” Annals of the Rheumatic Diseases, vol. 66, supplement 3, pp. iii87–iii90, 2007. View at Publisher · View at Google Scholar · View at Scopus